ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/Acetic acid;N-[1-(2-carbamoylpyrrolidin-1-yl)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
C38H56N12O14
904.9 g/mol
Research Reagent

Acetic acid;N-[1-(2-carbamoylpyrrolidin-1-yl)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide

CAS120876-23-5
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

This compound is a salt form of a synthetic peptide consisting of two units of a modified tripeptide, containing pyroglutamyl, histidyl, and prolinamide residues, with three molecules of acetic acid. It is used primarily as a research reagent.

research reagentlaboratory chemical synthesis

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.74

Taltirelin hydrate

CAS201677-75-0

pharmaceutical raw material

ReferenceSame Category

N4-benzoyl-2',3'-dideoxycytidine

CAS120885-60-1

research compound

ReferenceSame Category

Cyclooctadiene rhodium chloride dimer

CAS12092-47-6

research compound

ReferenceSame Category

2-Amino-5-bromo-3-fluorobenzonitrile

CAS1209498-46-3

research compound

ReferenceSame Category

Dimethyl 4-aminothiophene-2,3-dicarboxylate hydrochloride

CAS121071-71-4

research compound

Referencestereoisomer of

Thyrotropin-releasing hormone

CAS24305-27-9

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

acetic acid;bis(N-[1-(2-carbamoylpyrrolidin-1-yl)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide)

InChIKey

FCUSEANSBYKTPA-UHFFFAOYSA-N

SMILES

CC(=O)O.CC(=O)O.CC(=O)O.C1CC(N(C1)C(=O)C(CC2=CN=CN2)NC(=O)C3CCC(=O)N3)C(=O)N.C1CC(N(C1)C(=O)C(CC2=CN=CN2)NC(=O)C3CCC(=O)N3)C(=O)N

Synonyms (1)

—

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→